A Philadelphia jury decided Janssen Pharmaceuticals must pay over $10 million in damages to the parents of a five-year-old boy who developed cleft lip and other birth defects after being exposed to the anticonvulsant drug Topamax during his mother's ... Digital Journal, 3 weeks ago
KV Pharmaceutical Company Completes New Board with Appointment of Former Johnson & Johnson Executive
K-V Pharmaceutical Company ("KV") today announced the appointment of Janet Vergis to its Board of Directors. Ms. Vergis currently serves as the Executive-In-Residence at Warburg Pincus, LLC. Previously, she was the CEO of OraPharma, Inc. where she ...Individual.com, 1 month ago KV Pharmaceutical Completes New Board With Appointment of Former Johnson & Johnson (JNJ) Executive FierceBiotech, 1 month ago KV Pharmaceutical Completes New Board With Appointment of Former Johnson & Johnson Executive BioSpace, 1 month ago
The report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how ...TMC Net, 6 days ago
on your WebpageAdd Widget >Get your members hooked!